WGRX – wellgistics health, inc. (US:NASDAQ)

News

Wellgistics Health (NASDAQ:WGRX) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Wellgistics Health (NASDAQ:WGRX) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Datavault AI Licenses Patents Covering Digital Ledger-Enabled Smart Contracts for Commercial Prescription Drug Distribution Industry to Wellgistics Health [Yahoo! Finance]
Wellgistics Health (NASDAQ:WGRX) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Wellgistics Health GAAP EPS of -$0.46, revenue of $3.01M [Seeking Alpha]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com